413 related articles for article (PubMed ID: 6239742)
1. Auranofin.
Davis P
Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
[TBL] [Abstract][Full Text] [Related]
2. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
[No Abstract] [Full Text] [Related]
3. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
Davis P; Menard H; Thompson J; Harth M; Beaudet F
J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
[TBL] [Abstract][Full Text] [Related]
4. Review of auranofin, an oral chrysotherapeutic agent.
Delafuente JC; Osborn TG
Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
[TBL] [Abstract][Full Text] [Related]
5. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
6. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
Batlle Gualda E
Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
[No Abstract] [Full Text] [Related]
7. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
8. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
[TBL] [Abstract][Full Text] [Related]
9. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
[TBL] [Abstract][Full Text] [Related]
10. Injectable gold dermatitis and proteinuria: retreatment with auranofin.
Tosi S; Cagnoli M; Guidi G; Murelli M; Messina K; Colombo B
Int J Clin Pharmacol Res; 1985; 5(4):265-8. PubMed ID: 2932399
[TBL] [Abstract][Full Text] [Related]
11. [The pharmacology of gold compounds].
Juan H
Wien Klin Wochenschr Suppl; 1984; 156():7-13. PubMed ID: 6442062
[TBL] [Abstract][Full Text] [Related]
12. Auranofin therapy in rheumatoid arthritis.
Bernhard GC
J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of auranofin: a review of clinical experience.
Blodgett RC; Pietrusko RG
Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943
[TBL] [Abstract][Full Text] [Related]
14. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
Goebel KM; Storck U
Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
16. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
Bernhard GC
J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
Horton RJ
Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
[TBL] [Abstract][Full Text] [Related]
18. Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities.
van Riel PL; Gribnau FW; van de Putte LB; Yap SH
J Rheumatol; 1983 Apr; 10(2):222-6. PubMed ID: 6408256
[TBL] [Abstract][Full Text] [Related]
19. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function.
Lorber A; Kunishima DH; Harralson AF; Simon TM
J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684
[TBL] [Abstract][Full Text] [Related]
20. [Experiences to date with oral gold therapy].
Zeidler H
Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
